Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BJU International|July 13, 2006
Risk factors for a poor outcome after therapy for acute pyelonephritisPeter E Pertel, Daniel Haverstock
The European Respiratory Journal|October 29, 2011
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysisMarc Miravitlles, Frank Kruesmann, Daniel Haverstock, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 18, 2015
Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPDRobert Wilson, Antonio Anzueto, Marc Miravitlles, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 18, 2020
Diagnostic efficacy of contrast-enhanced breast MRI versus X-ray mammography in women with different degrees of breast densityJörg Barkhausen, Arpad Bischof, Daniel Haverstock, et al.
The Laryngoscope|April 28, 2010
Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitisJames A Hadley, Ralph Mösges, Martin Desrosiers, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 16, 2011
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodologyRobert Wilson, Antonio Anzueto, Marc Miravitlles, et al.
The European Respiratory Journal|December 3, 2011
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL resultsRobert Wilson, Antonio Anzueto, Marc Miravitlles, et al.
Pageof 2